Long-term Safety and Efficacy Extension Trial of Bimatoprost SR
Status:
Enrolling by invitation
Trial end date:
2025-06-13
Target enrollment:
Participant gender:
Summary
This study will evaluate the long-term safety and efficacy of Bimatoprost SR in patients with
open-angle glaucoma or ocular hypertension who completed 1 of the 4 Phase 3 Bimatoprost SR
studies (192024-091, -092, -093, or -095) and received Bimatoprost SR.